Related references
Note: Only part of the references are listed.Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
Kim N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Epidemiology and genomics of prostate cancer in Asian men
Yao Zhu et al.
NATURE REVIEWS UROLOGY (2021)
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
Yukihide Momozawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes
Jennifer L. Beebe-Dimmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Veda N. Giri et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer
Yishuo Wu et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
Piper Nicolosi et al.
JAMA ONCOLOGY (2019)
Prostate Cancer, Version 2.2019
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Heather H. Cheng et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Germline DNA Repair Gene Mutation Landscape in Chinese Prostate Cancer Patients
Yu Wei et al.
EUROPEAN UROLOGY (2019)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion
Ahmad N. Abou Tayoun et al.
HUMAN MUTATION (2018)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study
Ola Bratt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study
Ola Bratt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Racial/Ethnic Disparities in Genomic Sequencing
Daniel E. Spratt et al.
JAMA ONCOLOGY (2016)
Germline Variants of Prostate Cancer in Japanese Families
Takahide Hayano et al.
PLOS ONE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Prostate Cancer Risk Prediction Based on Complete Prostate Cancer Family History
Frederick Albright et al.
PROSTATE (2015)
Risk of Prostate Cancer in Lynch Syndrome: A Systematic Review and Meta-analysis
Shae Ryan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Charles M. Ewing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis
Michal Kicinski et al.
PLOS ONE (2011)
Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
David J. Gallagher et al.
CLINICAL CANCER RESEARCH (2010)
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
A Liede et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
